NCT03073343View on ClinicalTrials.gov

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 12, 2013

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Non-Alcoholic Fatty Liver DiseaseNon Insulin Dependent DiabetesALT
Interventions
DIETARY_SUPPLEMENT

Betaine (trimethyglycine)

Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.

Trial Locations (1)

90822

RECRUITING

VA Long Beach Healthcare System, Long Beach

All Listed Sponsors
lead

Southern California Institute for Research and Education

OTHER